Koyfin Home > Directory > Health Care > Retrophin Inc > Cost of Goods Sold

Retrophin Inc Cost of Goods Sold Chart (RTRX)

Retrophin Inc annual/quarterly Cost of Goods Sold from 2013 to 2020.
  • Retrophin Inc Cost of Goods Sold for the quarter ending June 06, 2020 was $1m a -1.27% decrease of 0m year over year
  • Retrophin Inc Cost of Goods Sold for the last 12 months ending June 06, 2020 was $6m a 16.22% increase of 1m year over year
  • Retrophin Inc Annual Cost of Goods Sold for 2019 was $5m a -5.60% decrease of 0m from 2018
  • Retrophin Inc Annual Cost of Goods Sold for 2018 was $6m a 34.77% increase of 2m from 2017
  • Retrophin Inc Annual Cost of Goods Sold for 2017 was $4m a -26.32% decrease of -1m from 2016
Other Income Statement Metrics:
  • Retrophin Inc EBITDA for the quarter ending December 12, 2018 was $-11m a 8.86% decrease of -1m year over year
  • Retrophin Inc Net Income for the quarter ending December 12, 2018 was $-7m a -146.52% increase of 11m year over year
  • Retrophin Inc Total Revenue for the quarter ending September 09, 2018 was $41m a -3.61% decrease of -1m year over year
View Chart On Koyfin

Quarterly RTRX Cost of Goods Sold Data

06/2020$1m
03/2020$1m
12/2019$2m
09/2019$2m
06/2019$1m
03/2019$1m
12/2018$2m
09/2018$1m
06/2018$1m
03/2018$2m

Annual RTRX Cost of Goods Sold Data

2019$5m
2018$6m
2017$4m
2016$5m
2015$2m
2014$1m